Welcome to AIMday Diabetes
Navet, BMC, Uppsala on June 5, 2019
Diabetes is a serious, chronic disease characterized by elevated levels of blood glucose, which leads over time to serious damage to the heart, blood vessels, eyes, kidneys, and nerves. Diabetes is a major public health concern and is one of four prioritised noncommunicable diseases (NCDs) targeted for action by world leaders. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades, and globally caused 1.5 million deaths in 2012. Diabetes and its complications severely affect the quality of life for patients and their families, as well as imposing a large cost on the health care system. There is a large need to find new innovative solutions for improved prevention, diagnosis and treatment of both diabetes and diabetes complications. AIMday Diabetes is a meeting focused on bringing academic scientists, clinicians and company representatives together for discussions on new collaborative approaches and solutions to tackle the disease, for the benefit of patients and society.
Foto: Mikael Wallerstedt
Registration for companies is open and will close on 16 April.
Registration for academic scientists will open 23 April and close on 25 May.
Registration for all participants is free of charge.
Read more about how AIMday works
AIMday Diabetes is arranged by UU Innovation